222 related articles for article (PubMed ID: 36913408)
21. A Human Ex Vivo Skin Model to Study Candida auris Biofilms.
Corzo-León DE; Mark C; MacCallum DM; Munro CA
Methods Mol Biol; 2022; 2517():259-267. PubMed ID: 35674961
[TBL] [Abstract][Full Text] [Related]
22. Activities of nine antifungal agents against Candida auris biofilms.
Chatzimoschou A; Giampani A; Meis JF; Roilides E
Mycoses; 2021 Apr; 64(4):381-384. PubMed ID: 33270284
[TBL] [Abstract][Full Text] [Related]
23. Filamentous growth is a general feature of Candida auris clinical isolates.
Fan S; Yue H; Zheng Q; Bing J; Tian S; Chen J; Ennis CL; Nobile CJ; Huang G; Du H
Med Mycol; 2021 Jul; 59(7):734-740. PubMed ID: 33485272
[TBL] [Abstract][Full Text] [Related]
24. A biological and genomic comparison of a drug-resistant and a drug-susceptible strain of
Fan S; Zhan P; Bing J; Jiang N; Huang Y; Chen D; Hu T; Du H; Huang G
Virulence; 2021 Dec; 12(1):1388-1399. PubMed ID: 34060424
[TBL] [Abstract][Full Text] [Related]
25. Candida auris, a singular emergent pathogenic yeast: its resistance and new therapeutic alternatives.
Fernandes L; Ribeiro R; Henriques M; Rodrigues ME
Eur J Clin Microbiol Infect Dis; 2022 Dec; 41(12):1371-1385. PubMed ID: 36198878
[TBL] [Abstract][Full Text] [Related]
26. What do we know about the biology of the emerging fungal pathogen of humans Candida auris?
Bravo Ruiz G; Lorenz A
Microbiol Res; 2021 Jan; 242():126621. PubMed ID: 33096325
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of biofilm disrupters against Candida auris and other Candida species in monomicrobial and polymicrobial biofilms.
Cox CA; Manavathu EK; Wakade S; Myntti M; Vazquez JA
Mycoses; 2024 Jan; 67(1):e13684. PubMed ID: 38214428
[TBL] [Abstract][Full Text] [Related]
28. Conserved Role for Biofilm Matrix Polysaccharides in
Dominguez EG; Zarnowski R; Choy HL; Zhao M; Sanchez H; Nett JE; Andes DR
mSphere; 2019 Jan; 4(1):. PubMed ID: 30602527
[No Abstract] [Full Text] [Related]
29. Colonized patients by
de Melo CC; de Sousa BR; da Costa GL; Oliveira MME; de Lima-Neto RG
Front Cell Infect Microbiol; 2023; 13():1033707. PubMed ID: 36756619
[TBL] [Abstract][Full Text] [Related]
30. Photodynamic Therapy Is Effective Against
Bapat PS; Nobile CJ
Front Cell Infect Microbiol; 2021; 11():713092. PubMed ID: 34540717
[TBL] [Abstract][Full Text] [Related]
31. Abrogation of efflux pump activity, biofilm formation, and immune escape by candidacidal geraniol in emerging superbug, Candida auris.
Fatima T; Fatima Z; Hameed S
Int Microbiol; 2023 Nov; 26(4):881-891. PubMed ID: 36847907
[TBL] [Abstract][Full Text] [Related]
32. Identification of Candida auris by PCR and assessment of biofilm formation by crystal violet assay.
Singh P; Srivastava S; Malhotra R; Mathur P
Indian J Med Microbiol; 2023; 46():100421. PubMed ID: 37945115
[TBL] [Abstract][Full Text] [Related]
33. Caspofungin-resistance in Candida auris is cell wall-dependent phenotype and potential prevention by zinc oxide nanoparticles.
Fayed B; Jayakumar MN; Soliman SSM
Med Mycol; 2021 Dec; 59(12):1243-1256. PubMed ID: 34612496
[TBL] [Abstract][Full Text] [Related]
34. The adhesin SCF1 mediates Candida auris colonization.
Balakumar A; Bernstein D; Thangamani S
Trends Microbiol; 2024 Jan; 32(1):4-5. PubMed ID: 37951769
[TBL] [Abstract][Full Text] [Related]
35. Adenylyl Cyclase and Protein Kinase A Play Redundant and Distinct Roles in Growth, Differentiation, Antifungal Drug Resistance, and Pathogenicity of
Kim JS; Lee KT; Lee MH; Cheong E; Bahn YS
mBio; 2021 Oct; 12(5):e0272921. PubMed ID: 34663094
[TBL] [Abstract][Full Text] [Related]
36. ClaID: a Rapid Method of Clade-Level Identification of the Multidrug Resistant Human Fungal Pathogen Candida auris.
Narayanan A; Selvakumar P; Siddharthan R; Sanyal K
Microbiol Spectr; 2022 Apr; 10(2):e0063422. PubMed ID: 35343775
[TBL] [Abstract][Full Text] [Related]
37. Miltefosine as an alternative strategy in the treatment of the emerging fungus Candida auris.
Barreto TL; Rossato L; de Freitas ALD; Meis JF; Lopes LB; Colombo AL; Ishida K
Int J Antimicrob Agents; 2020 Aug; 56(2):106049. PubMed ID: 32544569
[TBL] [Abstract][Full Text] [Related]
38. A Culture Supernatant from an Actinomycete sp. Affects Biofilm Formation and Virulence Expression of Candida auris.
Yamane K; Niki M; Tsubouchi T; Watanabe T; Asai K; Oinuma KI; Sakiyama A; Saren C; Matsumoto Y; Makimura K; Kaneko Y; Kawaguchi T
Med Mycol J; 2023; 64(1):7-17. PubMed ID: 36858631
[TBL] [Abstract][Full Text] [Related]
39. Ceragenins are active against drug-resistant Candida auris clinical isolates in planktonic and biofilm forms.
Hashemi MM; Rovig J; Holden BS; Taylor MF; Weber S; Wilson J; Hilton B; Zaugg AL; Ellis SW; Yost CD; Finnegan PM; Kistler CK; Berkow EL; Deng S; Lockhart SR; Peterson M; Savage PB
J Antimicrob Chemother; 2018 Jun; 73(6):1537-1545. PubMed ID: 29635279
[TBL] [Abstract][Full Text] [Related]
40. Withania somnifera seed oil exhibits antibiofilm properties against drug-resistant Candida auris clinical isolate through modulation in cell permeability.
Balkrishna A; Kharayat B; Rastogi S; Kabdwal M; Haldar S; Varshney A
J Appl Microbiol; 2023 Jun; 134(6):. PubMed ID: 37096387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
